Following completion of his PhD at Imperial College, London, Dr Andrew Macadam moved to NIBSC as a postdoc in 1987 working on the molecular basis of attenuation of poliovaccines. He joined the staff permanently in the 1990s and is currently a Principal Scientist in the Division of Virology where he runs a research group with interests in new approaches to polio vaccine design.
Principal Scientist, Division of Virology
Poliovirus biologyMolecular basis of attenuationNew approaches to vaccine design
BA Biochemistry. Oxford University, 1982PhD, University of London, 1987